WHO ICTRP trial
Generation of circulating tumor cell derived organoids through enrichment by…
NL-OMON46104 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON46104 |
|---|---|
| Public title | Generation of circulating tumor cell derived organoids through enrichment by leukapheresis - A novel drug screening system in metastatic prostate cancer |
| Scientific title | Generation of circulating tumor cell derived organoids through enrichment by leukapheresis - A novel drug screening system in metastatic prostate cancer - Circle study |
| Primary sponsor | Erasmus MC, Universitair Medisch Centrum Rotterdam |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Observational invasive |
| Countries | The Netherlands |
| Conditions | prostate cancer prostate carcinoma;10038364;prostate cancer;prostate carcinoma |
| Interventions | ;circulating tumor cells;leukapheresis;organoids;prostate cancer |
| Registration date | Jun 23, 2017 |
| Target size | 79 |
| Secondary IDs | NL57710.078.16;NTR6150 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: